Carolina Engagement Week 2025 brings together Carolina faculty, staff and students with community partners to learn about and celebrate engagement and collaboration with North Carolina communities.

Register for the events you want to attend and participate in skill-building workshops, research presentations, panel discussions and more!

View the events at engagementweek.unc.edu/events-calendar.

This online training will provide an introduction to qualitative data analysis, focusing on content/thematic analysis. The session will cover the basics of qualitative data analysis and steps in the analysis process, including transcribing, memoing, codebook development and coding, exploring content areas or themes, and interpreting and communicating findings. Participants will have the opportunity to practice developing and applying codes.

Please note: We will not be demonstrating how to use qualitative data analysis software during this session.

Presenters:

MaryBeth Grewe, MPH
Program Manager, Qualitative Research Service
Research Specialist, Patient and Community Engagement in Research (PaCER) Program
NC TraCS Institute

Simone Frank, MPH
Senior Project Manager, Patient and Community Engagement in Research (PaCER) Program
Research Specialist, Qualitative Research Service
NC TraCS Institute

Register

The NIH is postponing Rare Disease Day 2025 and will reschedule it to occur in the coming months.

FDA-NIH Rare Disease Day is scheduled for February 27–28, 2025.

This year, NCATS is co-hosting with the U.S. Food and Drug Administration (FDA) to provide a free, public event held on the NIH Main Campus at the Natcher Conference Center and virtually. Rare Disease Day aims to raise awareness about rare diseases, the people they affect and NIH and FDA collaborations that address scientific challenges and advance research for new treatments.

The goals of FDA-NIH Rare Disease Day are to:

• Demonstrate the NIH and FDA commitment to advancing research and regulatory support for people affected by rare diseases.
• Highlight NIH and FDA supported rare diseases research and the development of diagnostics and treatments.
• Initiate a mutually beneficial dialogue among the rare diseases community.
• Exchange the latest rare diseases information with stakeholders to advance research and therapeutic efforts.
• Shine a spotlight on stories told by patients living with a rare disease, their caregivers, and their communities.

FDA-NIH Rare Disease Day seeks to bring together a broad audience including patients, patient advocates, caregivers, health care providers, researchers, trainees, students, industry representatives, and government staff. 

For more details, visit ncats.nih.gov.

register

The NIH is postponing Rare Disease Day 2025 and will reschedule it to occur in the coming months.

FDA-NIH Rare Disease Day is scheduled for February 27–28, 2025.

This year, NCATS is co-hosting with the U.S. Food and Drug Administration (FDA) to provide a free, public event held on the NIH Main Campus at the Natcher Conference Center and virtually. Rare Disease Day aims to raise awareness about rare diseases, the people they affect and NIH and FDA collaborations that address scientific challenges and advance research for new treatments.

The goals of FDA-NIH Rare Disease Day are to:

• Demonstrate the NIH and FDA commitment to advancing research and regulatory support for people affected by rare diseases.
• Highlight NIH and FDA supported rare diseases research and the development of diagnostics and treatments.
• Initiate a mutually beneficial dialogue among the rare diseases community.
• Exchange the latest rare diseases information with stakeholders to advance research and therapeutic efforts.
• Shine a spotlight on stories told by patients living with a rare disease, their caregivers, and their communities.

FDA-NIH Rare Disease Day seeks to bring together a broad audience including patients, patient advocates, caregivers, health care providers, researchers, trainees, students, industry representatives, and government staff. 

For more details, visit ncats.nih.gov.

register

Behavioral Economic and Staffing Strategies To Increase Adoption of the ABCDEF Bundle in the Intensive Care Unit (BEST ICU): Protocol, Challenges, and Major Updates

This NIH Collaboratory Rethinking Clinical Trials Grand Rounds features:

Michele C. Balas PhD, RN, CCRN-K, FCCM, FAAN
Associate Dean of Research
Dorothy Hodges Olson Distinguished Professor of Nursing
University of Nebraska Medical Center College of Nursing

Eduard Vasilevskis, MD, MPH
Professor of Medicine
Department of Medicine, Division of Hospital Medicine
University of Wisconsin-Madison

Learn More